Outset Medical Inc(OM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.1 | Insider Own | 5.9% | Shs Outstand | 18.8M | Perf Week | -9.96% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 25.7% | Insider Trans | -3.14% | Shs Float | 17.7M | Perf Month | -28.67% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.69 | Inst Own | 74.23% | Short Float | 5.1% | Perf Quarter | -25.35% |
| Income | -0.07B | P/S | 0.51 | EPS this Y | 28.22% | Inst Trans | -9.25% | Short Ratio | 4.59 | Perf Half Y | 1.58% |
| Sales | 0.12B | P/B | 0.63 | EPS next 5Y | 24.51% | ROA | -27.97% | Short Interest | 0.90M | Perf YTD | -13.48% |
| Book/sh | 5.13 | P/C | 0.41 | EPS past 3/5Y | 52.71% 28.06% | ROE | -59.17% | 52W High | -80.14% ($16.16) | Perf Year | -77.31% |
| Cash/sh | 7.84 | P/FCF | - | Sales past 3/5Y | 1.17% 19.06% | ROIC | -37.48% | 52W Low | 7% ($3.00) | Perf 3Y | -98.45% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.82% | Gross Margin | 41.76% | Volatility(W/M) | 4.98% 6.38% | Perf 5Y | -99.58% |
| Dividend TTM | - | EV/Sales | 0.15 | Sales Y/Y TTM | -1.26% | Oper. Margin | -55.82% | ATR (14) | 0.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.11 | EPS Q/Q | 7.57% | Profit Margin | -63.06% | RSI (14) | 26.32 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.19 | Sales Q/Q | 0.69% | SMA20 | -18.04% ($3.92) | Beta | 1.98 | Target Price | $7.67 |
| Payout | - | Debt/Eq | 1.08 | Earnings | 2026/8/6 | SMA50 | -25.56% ($4.31) | Rel Volume | 0.45 | Prev Close | $3.27 |
| Employees | 310 | LT Debt/Eq | 1.06 | EPS/Sales Surpr. | -11.62% 9.21% | SMA200 | -24.15% ($4.23) | Avg Volume(3M) | 0.20M | Price | $3.21 |
| IPO | 2020/9/15 | Option/Short | Yes/Yes | Trades | 732 | Volume | 89,078 | Change | -1.83% |
Company
아웃셋 의료OM | NASD | Medical Devices OM is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A U.S. medical device company that develops and supplies the touchscreen-based hemodialysis system "Tablo." Founded in 2003 and headquartered in the United States, the company offers dialysis equipment and consumables usable in both hospital and home settings, along with subscription-based software and services.
Over the past 1 year, on the lower side
80% below its 1-year high.
OM has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +28.2% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -98.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 74.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FMED 0.00%
LYTE 0.00%
IWC 0.00%
CAS 0.00%
DFSU 0.00%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
BND 162.3B
GLD 147.4B
AGG 137.2B
SGOV 109.4B
BNDX 82.7BIt ranks #4 in the industry
Based on market cap of $60M.
OM $60M PER -
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is OM?
OM belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of OM?
The market cap of OM is approximately $60M, ranking 4,861 within its sector.
What is the 52-week high and low for OM?
OM has recorded a 52-week high of $16.16 and a low of $3.00.
